[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f4j2jyw0iezcd":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"name":15,"company":16,"products":21,"catalysts":30},"EXELIXIS INC",{"name":17,"ticker":18,"exchange":19,"cik":20},"Exelixis Inc","EXEL","Nasdaq","0000939767",[22],{"tradeName":23,"slug":24,"ingredient":25,"applNo":26,"loe":27,"basis":28,"carveOutPossible":13,"strengths":29},"CABOMETYX","cabometyx","CABOZANTINIB S-MALATE","208692","2033-07-09","patent",3,[31,40,47],{"id":32,"type":33,"eventDate":34,"detectedAt":35,"tradeName":23,"slug":24,"payload":36},2585,"FIRST_GENERIC_APPROVED","2026-08-14","2026-10-25T00:14:04.459Z",{"note":37,"andaNo":38,"sponsor":39,"ingredient":25},"first approved ANDA seen for this RLD in Drugs@FDA; verify against FDA first-generics list","213878","MSN",{"id":41,"type":42,"eventDate":34,"detectedAt":43,"tradeName":23,"slug":24,"payload":44},2584,"ANDA_APPROVED","2026-10-25T00:14:04.299Z",{"route":45,"andaNo":38,"sponsor":39,"dosageForm":46,"ingredient":25},"ORAL","TABLET",{"id":48,"type":42,"eventDate":49,"detectedAt":50,"tradeName":23,"slug":24,"payload":51},2209,"2026-10-16","2026-10-25T00:13:07.885Z",{"route":45,"andaNo":52,"sponsor":53,"dosageForm":46,"ingredient":25},"217870","CIPLA"]